Florida Senate - 2012 COMMITTEE AMENDMENT
Bill No. SB 668
Barcode 279032
LEGISLATIVE ACTION
Senate . House
Comm: RS .
02/23/2012 .
.
.
.
—————————————————————————————————————————————————————————————————
—————————————————————————————————————————————————————————————————
The Committee on Health Regulation (Fasano) recommended the
following:
1 Senate Amendment to Amendment (766998) (with title
2 amendment)
3
4 Delete line 60
5 and insert:
6 Section 2. Effective upon this act becoming a law and
7 before July 1, 2012, the Office of Insurance Regulation shall
8 conduct a retrospective review of any rate filing submitted by a
9 rating organization on behalf of workers’ compensation or
10 employer’s liability insurance carriers during the previous 12
11 months which resulted in a rate increase. The office’s review
12 must determine whether the information, data, and documentation
13 included in the rate filings include cost information
14 demonstrating that 2.5 percent of the overall rate increase that
15 was subsequently approved was directly attributable to the costs
16 of repackaging prescription medications. If the office
17 determines that such documentation or information was not
18 included in the rate filing, the office shall immediately reduce
19 the rates of workers’ compensation and employer liability
20 insurance carriers by 2.5 percent. The office shall also make
21 its review available to the Senate and the House of
22 Representatives by October 1, 2012.
23 Section 3. Except as otherwise expressly provided in this
24 act and except for this section, which shall take effect upon
25 this act becoming a law, this act shall take effect July 1,
26 2012.
27
28 ================= T I T L E A M E N D M E N T ================
29 And the title is amended as follows:
30 Delete lines 76 - 77
31 and insert:
32 medication; providing limitations; requiring the
33 Office of Insurance Regulation to conduct a
34 retrospective review of certain rate filings to
35 determine if the filings were supported by
36 documentation demonstrating that a certain portion of
37 the approved rate increase was attributable to the
38 costs of repackaging prescription medications and to
39 reduce rates if not so supported; providing effective
40 dates.